Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 446

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1C
Chunk 446
---
 CORP.

    By:
    /s/
    Deepika Vuppalanchi

    Deepika
    Vuppalanchi

    Chief
    Executive Officer and Director

-41-

POWER
OF ATTORNEY 

KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Deepika Vuppalanchi as
his or her attorney-in-fact, with full power of substitution and resubstitution, for him or her in any and all capacities, to sign any
and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact full power and authority to do and perform
each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might
or could do in person, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may lawfully
do or cause to be done by virtue hereof.

Pursuant
to the requirements of the Securities Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on
behalf of the registrant and in the capacities and on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/
    Deepika Vuppalanchi
     
    Chief
    Executive Officer (Principal Executive Officer)
     
    March
    11, 2025 
  
    Deepika
    Vuppalanchi

    /s/
    Priya Prasad
     
    Chief
    Financial Officer and Chief Operating Officer
     
     March
    11, 2025 
  
    Priya
    Prasad
     
    (Principal
    Financial and Accounting Officer)

    /s/
    Sherron Rogers
     
    Director
     
    March
    11, 2025 
  
    Sherron
    Rogers

    /s/
    Andrew M. Dahlem
     
    Director
     
    March
    11, 2025 
  
    Andrew
    M. Dahlem

    /s/
    Vijayapal R. Reddy
     
    Director
     
    March
    11, 2025